Page 2 - பயனற்ற உலோகங்கள் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பயனற்ற உலோகங்கள் சந்தை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பயனற்ற உலோகங்கள் சந்தை Today - Breaking & Trending Today

FDA approves Oncopeptides' PEPAXTO ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma

FDA approves Oncopeptides PEPAXTO ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO
), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that the U.S. Food and Drug Administration, FDA, has approved PEPAXTO
(melphalan flufenamide, also known as melflufen), in combination with dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody. ....

United States , United Kingdom , Martyj Duvall , Anders Martin , Ola Landgren , Rolf Gulliksen , Klaas Bakker , Linda Holmstr , Jakob Lindberg , Leader Of Experimental Therapeutics Program , Myeloma Program , Sylvester Comprehensive Cancer Center , Drug Administration , Global Head Of Corporate Communications , University Of Miami Health System In , Division Of Hematology , Nasdaq Stockholm , Chief Executive Officer , New Drug Application , Chief Scientific Officer , Professor Ola Landgren , Experimental Therapeutics Program , Miami Health System , Overall Response Rate , Median Duration , Extra Medullary Disease ,

The future of manufacturing and infrastructure industry

The future of manufacturing and infrastructure industry
ANI |
Updated: Feb 24, 2021 12:48 IST
New Delhi [India], February 24 (ANI/SRV Media): What exactly is the future of the manufacturing and infrastructure industry in India? What are the prospects of expanding the industries globally? Simplex Coke and Refractory, is the fourth largest manufacturer of coke and provider of piling rigs on rent, with multiple interests and aspects in the infrastructure business.
The company is a prominent low ash metallurgical coke and refractory manufacturer in India. It is also called SCORE and the technology provided enables large-scale high-quality coke.
Simplex Coke and Refractory have a fully stamped charging coke technology which makes the plant one of the most advanced technology plants in western India. It has three business divisions, namely - coke division, refractory division, and power division. ....

India General , New Delhi , Vatsal Agarwal , Narendra Modi , Aditya Birla , Aatma Nirbhar , Mithibai College , Tata Chemicals , Hindustan Zinc , Simplex Coke , Ghadi Detergent , Tata Chemicals Limited , Hindustan Zinc Limited , Refractory Division , Prime Minister , இந்தியா ஜநரல் , புதியது டெல்ஹி , வாட்சல் அகர்வால் , நரேந்திர மோடி , ஆத்ம நிர்பர் , மிதிபாய் கல்லூரி , டாடா இரசாயனங்கள் , ஹிந்துஸ்தான் ஸிஂக் , சிம்ப்ளக்ஸ் கோக் , காதி சோப்பு , டாடா இரசாயனங்கள் வரையறுக்கப்பட்டவை ,

Asian Cement cement plant upgrades inlet chamber and riser duct with Hasle lining

Asian Cement plant upgrades inlet chamber and riser duct with Hasle lining
Written by Global Cement staff
11 February 2021
India: Denmark-based Hasle has supplied a Hasle D59A coating-resistant castable to Asian Cement for use on the inlet chamber and riser duct at its cement plant. The supplier supervised installation. It said that the castable will reduce the required lining materials of the equipment, resulting in savings.
Last modified on 17 February 2021 ....

Denmark Based Hasle , Asian Cement , Asia Cement , ஆசிய சிமென்ட் , ஆசியா சிமென்ட் ,

Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL

(1)
Umbralisib (UKONIQ) granted accelerated approval by US FDA for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL), follicular lymphoma (FL).
Umbralisib, a novel next generation inhibitor of PI3K delta CK1 epsilon, was discovered by Rhizen Pharmaceuticals and subsequently licensed to TG Therapeutics, who led the asset s clinical development.
Rhizen and its affiliate Alembic Pharma to support TG Therapeutics towards UKONIQ s commercialization as its manufacturing supply partner; Rhizen plans to register and commercialize Umbralisib in India.
Rhizen Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company, today announced that its novel next generation PI3K-delta inhibitor, Umbralisib, which was licensed to TG Therapeutics (NASDAQ:TGTX), has secured US FDA accelerated approval for the treatment of: ....

Samyukta Bhagwati , Kostenloser Wertpapierhandel , Swaroop Vakkalanka , Rhizen Pharma , Pranav Amin , Alembic Pharmaceuticals , Rhizen Pharmaceuticals , Corporate Affairs Communications , Alembic Pharmaceuticals Ltd , Alembic Pharma , Breakthrough Therapy Designation , Rhizen Pharmaceuticals Managing Director , Pharmaceuticals Limited , சம்யுக்டா பகவதி , பிரணவ் அமின் , அலெம்பிக் மருந்துகள் , பெருநிறுவன வாழ்க்கைத்தொழில்கள் தகவல்தொடர்புகள் , அலெம்பிக் மருந்துகள் லிமிடெட் , அலெம்பிக் பார்மா , திருப்புமுனை சிகிச்சை பதவி , மருந்துகள் வரையறுக்கப்பட்டவை ,

Tripling the lifetime of lining

Tripling the lifetime of lining
Published 11 January 2021
A Vietnamese cement plant has more than tripled the lifetime of the refractory lining in its cooler bull nose by using a precast modular lining from HASLE Refractories. Abrasion and alkali attacks have been reduced significantly, while the solution is also extremely resistant to coating. By HASLE Refractories A/S, Denmark.
Figure 1: completed installation of HASLE precast Modular Lining in the cooler bull nose at a cement plant in Vietnam
A 5000tpd cement plant in Vietnam, running on 70 per cent coal and 30 per cent AFR, was having problems with short refractory life in its cooler bull nose. With a lifetime of no more than 8-12 months, the cement plant had to reline its cooler bull nose after each campaign. Relining the area not only required many manhours and materials but also took up valuable production time. To minimise downtime, the cement factory was looking for a longer-lasting refractory solution for ....

Republic Of , International Cement Review Or Login , Modular Lining , International Cement Review , Refractory Maintenance , South Asia , குடியரசு ஆஃப் , சர்வதேச சிமென்ட் விமர்சனம் அல்லது உள்நுழைய , மட்டு புறணி , சர்வதேச சிமென்ட் விமர்சனம் , பயனற்ற பராமரிப்பு , தெற்கு ஆசியா ,